By: W. Scott West, MD Technology continues to advance at a rapid pace across various industries, which closely mirrors the rate of adoption and usage
Healthcare treatment approaches change over time as discoveries and new technologies are tested and refined. The process of evidence-based research, learning and continuous improvement carries
In this blog feature, while I typically discuss more of the mechanics and scientific aspects of Transcranial Magnetic Stimulation (TMS) Therapy for depression, this time
[vc_row][vc_column][vc_column_text]What’s good for business should also be good for employees, as the majority of companies’ lifeblood depends on its workforce productivity. Recently, The American Psychiatric
Suicide is a critical issue in our society, and we continue to struggle with how to deal with it. The CDC’s latest release of statistics
The recent, tragic deaths of Kate Spade and Anthony Bourdain are a reminder of the battle so many of us are fighting, often silently. Depression
May 11 – 13, 2018 marked the Clinical TMS Society Annual Meeting, where 550+ attendees from more than 30 countries came together in Brooklyn, New
[vc_row][vc_column][vc_column_text]Dr. W. Scott West co-presented with Greg Harper, VP of Product Development & Operations of NeuroStar, at the 2018 Clinical TMS Society Annual Meeting. We
https://youtu.be/4Zt9giJr620 Dr. W. Scott West discusses Transcranial Magnetic Stimulation (TMS) Therapy using NeuroStar technology, the #1 TMS choice of doctors for the treatment of depression.
For a long time, it has been widely known that clinical depression is a complex mental illness. Depression interferes with the ability to live and
© 2022 All rights reserved
